Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-02-28 @ 12:03 AM
Study NCT ID:
NCT02602067
Status:
TERMINATED
Last Update Posted:
2018-09-18
First Post:
2015-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
Sponsor:
sigma-tau i.f.r. S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TENATUMOMAB/ST2146-CR-14-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |